G Paul Amminger

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi request reprint Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
    G Paul Amminger
    Department of Child and Adolescent Neuropsychiatry, Medical University of Vienna, Vienna, Austria
    Biol Psychiatry 61:551-3. 2007
  2. doi request reprint The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission
    Lisa P Henry
    ORYGEN Research Centre, Locked Bag 10, Parkville, Melbourne, Victoria, 3052, Australia
    J Clin Psychiatry 71:716-28. 2010
  3. doi request reprint Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Early Interv Psychiatry 6:450-4. 2012
  4. pmc Emotion recognition in individuals at clinical high-risk for schizophrenia
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Wahringer Gurtel, Austria
    Schizophr Bull 38:1030-9. 2012
  5. ncbi request reprint Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals
    G P Amminger
    ORYGEN Research Centre incorporating the PACE Clinic, Department of Psychiatry, University of Melbourne, Australia
    Schizophr Res 84:67-76. 2006
  6. ncbi request reprint Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000
    G P Amminger
    ORYGEN Research Centre Encompassing the Early Psychosis Prevention and Intervention Centre EPPIC, Department of Psychiatry, University of Melbourne, Melbourne, Australia
    Acta Psychiatr Scand 114:337-45. 2006
  7. ncbi request reprint Antibodies to infectious agents in individuals at ultra-high risk for psychosis
    G Paul Amminger
    ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Biol Psychiatry 61:1215-7. 2007
  8. doi request reprint Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome
    Patrick D McGorry
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
    J Clin Psychiatry 74:349-56. 2013
  9. ncbi request reprint Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Can J Psychiatry 58:402-8. 2013
  10. doi request reprint Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Arch Gen Psychiatry 67:146-54. 2010

Detail Information

Publications31

  1. ncbi request reprint Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
    G Paul Amminger
    Department of Child and Adolescent Neuropsychiatry, Medical University of Vienna, Vienna, Austria
    Biol Psychiatry 61:551-3. 2007
    ..There is increasing evidence that fatty acid deficiencies or imbalances may contribute to childhood neurodevelopmental disorders...
  2. doi request reprint The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission
    Lisa P Henry
    ORYGEN Research Centre, Locked Bag 10, Parkville, Melbourne, Victoria, 3052, Australia
    J Clin Psychiatry 71:716-28. 2010
    ..To describe the longer-term clinical and functional outcome of a large, epidemiologic representative cohort of individuals experiencing a first episode of psychosis...
  3. doi request reprint Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Early Interv Psychiatry 6:450-4. 2012
    ..The study aims to investigate affect recognition in young people at different stages of psychotic illness...
  4. pmc Emotion recognition in individuals at clinical high-risk for schizophrenia
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Wahringer Gurtel, Austria
    Schizophr Bull 38:1030-9. 2012
    ..The results suggest a trait deficit and an involvement of the amygdala in the pathology of ultra high-risk states...
  5. ncbi request reprint Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals
    G P Amminger
    ORYGEN Research Centre incorporating the PACE Clinic, Department of Psychiatry, University of Melbourne, Australia
    Schizophr Res 84:67-76. 2006
    ..We examined if age of onset of psychiatric symptoms and/or sex predict conversion to non-affective or affective psychosis in individuals considered to be at ultra-high risk for schizophrenia...
  6. ncbi request reprint Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000
    G P Amminger
    ORYGEN Research Centre Encompassing the Early Psychosis Prevention and Intervention Centre EPPIC, Department of Psychiatry, University of Melbourne, Melbourne, Australia
    Acta Psychiatr Scand 114:337-45. 2006
    ..To identify the treated incidence of psychosis in catchment of the Early Psychosis Prevention and Intervention Centre (EPPIC), Melbourne, Australia...
  7. ncbi request reprint Antibodies to infectious agents in individuals at ultra-high risk for psychosis
    G Paul Amminger
    ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Biol Psychiatry 61:1215-7. 2007
    ..While there is evidence that some cases of schizophrenia may be associated with microbial infections, the role of microbial agents has not been investigated in people with emerging psychosis...
  8. doi request reprint Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome
    Patrick D McGorry
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
    J Clin Psychiatry 74:349-56. 2013
    ..The aim of this study was to determine which intervention was most effective at preventing transition to psychosis: cognitive therapy plus low-dose risperidone, cognitive therapy plus placebo, or supportive therapy plus placebo...
  9. ncbi request reprint Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Can J Psychiatry 58:402-8. 2013
    ....
  10. doi request reprint Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Arch Gen Psychiatry 67:146-54. 2010
    ..Given that omega-3 PUFAs are generally beneficial to health and without clinically relevant adverse effects, their preventive use in psychosis merits investigation...
  11. doi request reprint A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults
    Andreas Bechdolf
    ORYGEN Youth Health, Department of Youth Mental Health, University of Melbourne, Australia
    J Affect Disord 127:316-20. 2010
    ..In the current study, the predictive validity of these criteria were tested in help-seeking adolescents and young adults...
  12. doi request reprint Social cognition in clinical "at risk" for psychosis and first episode psychosis populations
    Andrew Thompson
    Orygen Youth Health and Research Centre, Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
    Schizophr Res 141:204-9. 2012
    ..The study aimed to compare the degree of impairment in social cognition in three groups: FEP, those at "ultra high risk" (UHR) for psychosis and healthy controls...
  13. doi request reprint Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis
    Alison R Yung
    ORYGEN Research Centre and University of Melbourne, Department of Psychiatry, 35 Poplar Rd, Parkville 3052, Victoria, Australia
    J Clin Psychiatry 72:430-40. 2011
    ..However, it is unclear which of these treatments are most effective, how long treatment should be given, and whether effects will be sustained over a prolonged period...
  14. doi request reprint The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Schizophr Res 141:210-4. 2012
    ..It may represent a useful screening tool for calling clinicians' attention to subjects with psychotic-like experiences...
  15. doi request reprint Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?
    Barnaby Nelson
    ORYGEN Research Centre, University of Melbourne, Parkville, Victoria, Australia
    Early Interv Psychiatry 3:83-93. 2009
    ..This paper attempts to integrate a strand of cognitive research in psychotic disorders (specifically, social cognition research) with phenomenological accounts of schizophrenia and other psychotic disorders...
  16. doi request reprint Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristics
    Lisa P Henry
    ORYGEN Research Centre, University of Melbourne, Melbourne, Victoria, Australia
    Early Interv Psychiatry 1:49-60. 2007
    ..This paper reports the rationale, methodology and baseline characteristics of a large long-term follow-up study of first-episode psychosis from a geographically defined catchment area...
  17. doi request reprint Intervention in individuals at ultra-high risk for psychosis: a review and future directions
    Patrick D McGorry
    Centre for Youth Mental Health, Orygen Youth Health Research Centre, University of Melbourne, Victoria, Australia
    J Clin Psychiatry 70:1206-12. 2009
    ..This article reviews intervention research in the ultra-high-risk phase of psychotic disorders...
  18. ncbi request reprint PACE: a specialised service for young people at risk of psychotic disorders
    Alison R Yung
    PACE Clinic, ORYGEN Youth Health, Melbourne, Vic, Australia
    Med J Aust 187:S43-6. 2007
    ....
  19. pmc Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis
    Thomas J Whitford
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC 3053, Australia
    Schizophr Res 135:175-80. 2012
    ....
  20. doi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study
    Gregor E Berger
    Department of Psychiatry, ORYGEN Research Centre, University of Melbourne, Parkville, Australia
    Neuropsychopharmacology 33:2467-73. 2008
    ..Larger confirmatory studies of these postulated metabolic brain effects of E-EPA are warranted...
  21. ncbi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial
    Gregor E Berger
    ORYGEN Research Centre incorporating the Early Psychosis Prevention and Intervention Centre EPPIC, University of Melbourne, Australia
    J Clin Psychiatry 68:1867-75. 2007
    ..To investigate if ethyl-eicosapentaenoic acid (E-EPA) augmentation improves antipsychotic efficacy and tolerability in first-episode psychosis (FEP)...
  22. ncbi request reprint From neuroprogression to neuroprotection: implications for clinical care
    Michael Berk
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Melbourne, Vic
    Med J Aust 193:S36-40. 2010
    ..These developments need to be combined with service initiatives to maximise the opportunities for early diagnosis and intervention...
  23. ncbi request reprint Polyunsaturated fatty acids in emerging psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Austria
    Curr Pharm Des 18:576-91. 2012
    ..The neuroprotective potential of n-3 LC-PUFAs for indicated prevention, i.e. delaying transition to psychosis in high-risk populations needs to be further explored...
  24. ncbi request reprint [Early detection of psychotic disorders]
    Miriam R Schäfer
    Universitätsklihik für Neuropsychi8trie des Kindes undJugendalters, Medizinische Universität Wien, Osterreich
    Neuropsychiatr 21:37-44. 2007
    ..In contrast to antipsychotics, Omega-3 fatty acids have a high acceptance among youth and parents. At this stage the role of Omega-3 fatty acids remains unclear because the trial is not finished yet...
  25. ncbi request reprint [Early recognition and intervention for schizophrenia]
    N Mossaheb
    Klinische Abteilung für Allgemeine Psychiatrie, Medizinische Universität Wien
    Nervenarzt 77:23-4, 27-30, 32-4. 2006
    ..In this review, prodromal signs and possibilities for early detection and intervention in schizophrenia are presented...
  26. doi request reprint Long-term Follow-up of a Group at Ultra High Risk ("Prodromal") for Psychosis: The PACE 400 Study
    Barnaby Nelson
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
    JAMA Psychiatry 70:793-802. 2013
    ..Individuals with a long duration of symptoms and poor functioning at the time of referral may need closer monitoring. Interventions to improve functioning and detect help-seeking UHR patients earlier also may be indicated. ..
  27. doi request reprint Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care
    Patrick D McGorry
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
    Curr Opin Psychiatry 24:301-6. 2011
    ..To provide an update of the recent studies on the age of onset of the major mental illnesses, with a special focus on the prospects for prevention and early intervention...
  28. ncbi request reprint Bioactive lipids in schizophrenia
    Gregor E Berger
    ORYGEN Youth Health and ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Int Rev Psychiatry 18:85-98. 2006
    ..This review investigates the role of bioactive lipids in schizophrenia and its treatment, as well as its potential use in prevention...
  29. doi request reprint Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group
    A Bechdolf
    Department of Psychiatry, University of Melbourne, Australia
    Acta Psychiatr Scand 121:377-84. 2010
    ..We aimed to replicate a recent finding of high prevalence of trauma history in patients at 'ultra-high risk' (UHR) of psychotic disorder and to investigate whether trauma predicts conversion to psychosis in this population...
  30. ncbi request reprint Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia
    G P Amminger
    Department of Psychiatry, Early Psychosis Prevention and Intervention Centre, MH SKY, University of Melbourne, Locked Bag 10, Parkville 3052, Melbourne, Vic, Australia
    Schizophr Res 54:223-30. 2002
    ..Studies investigating the association between DUP and outcome should control for potentially confounding variables. Early treatment of psychosis could help to reduce the prominent cognitive deficit in first-episode schizophrenia...
  31. pmc Age of onset of mental disorders: a review of recent literature
    Ronald C Kessler
    Department of Healthcare Policy, Harvard Medical School, Boston, MA 02115, USA
    Curr Opin Psychiatry 20:359-64. 2007
    ..The aim of this article is to review recent epidemiological research on age-of-onset of mental disorders, focusing on the WHO World Mental Health surveys...